ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,645, issued on April 14, was assigned to DJS Antibodies Ltd (Oxford, Great Britain).

"Antibodies which bind to lysophosphatidic acid receptor 1 (LPAR1)" was invented by Joseph Illingworth (Oxford, Great Britain), David Llewellyn (Oxford, Great Britain), Megan Ingham (Oxford, Great Britain) and Michael Steward (Oxford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided inter alia polypeptides such as antibodies or fragments thereof which bind to LPAR1."

The patent was filed on Sept. 2, 2022, under Application No. 17/902,449.

*For further information, including images, charts and tables, please visit: http://patft.uspto....